Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
  1. 4 Open-market sale Director sold 1,000 shares at $249.98 ($249,980)
  2. 4 Shares withheld for taxes EVP, Operations gave up 4,360 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP, Research and Development gave up 1,401 shares (to pay taxes)
  4. 4 Shares withheld for taxes SVP, Business Development gave up 991 shares (to pay taxes)
  5. 4 Shares withheld for taxes VP, Finance & CAO gave up 115 shares (to pay taxes)
  6. 4 Shares withheld for taxes EVP, HR gave up 2,803 shares (to pay taxes)
  7. 4 Shares withheld for taxes SVP & CCO gave up 435 shares (to pay taxes)
  8. 4 Shares withheld for taxes EVP, Gen. Counsel & Secy. gave up 4,360 shares (to pay taxes)
  9. 4 Shares withheld for taxes EVP Global Commercial Ops gave up 8,989 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chairman, CEO and President gave up 21,190 shares (to pay taxes)
  11. 4 Open-market sale Director sold 1,000 shares at $231.53 ($231,530)
  12. 4 Grant or award EVP, Operations acquired 8,725 shares (grant or award)
  13. 4 Grant or award EVP, Research and Development acquired 2,803 shares (grant or award)
  14. 4 Grant or award SVP, Business Development acquired 2,648 shares (grant or award)
  15. 4 Grant or award VP, Finance & CAO acquired 467 shares (grant or award)
  16. 4 Grant or award EVP, HR acquired 5,608 shares (grant or award)
  17. 4 Grant or award SVP & CCO acquired 1,245 shares (grant or award)
  18. 4 Grant or award EVP, Gen. Counsel & Secy. acquired 8,725 shares (grant or award)
  19. 4 Grant or award EVP Global Commercial Ops acquired 17,989 shares (grant or award)
  20. 4 Grant or award Chairman, CEO and President acquired 38,953 shares (grant or award)

Page 25 of 99 · 1,961 filings